围术期手术人群队列研究

注册号:

Registration number:

ChiCTR2000034039 

最近更新日期:

Date of Last Refreshed on:

2025-09-29 16:41:38 

注册时间:

Date of Registration:

2020-06-21 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

围术期手术人群队列研究

Public title:

A Perioperative Surgical Patient Cohort Study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

围术期手术人群队列研究

Scientific title:

A Perioperative Surgical Patient Cohort Study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

杨华珍 

研究负责人:

宋欢;李茜 

Applicant:

Huazhen Yang 

Study leader:

Huan Song, Qian Li 

申请注册联系人电话:

Applicant telephone:

+86 130 3288 0298

研究负责人电话:

Study leader's
telephone:

+86 61527998

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yanghuazhen@wchscu.cn

研究负责人电子邮件:

Study leader's E-mail:

songhuan@wchscu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省成都市武侯区国学巷37号

研究负责人通讯地址:

四川省成都市武侯区国学巷37号

Applicant address:

No. 37, Guoxue Lane, Wuhou District, Chengdu City, Sichuan Province

Study leader's address:

No. 37, Guoxue Lane, Wuhou District, Chengdu City, Sichuan Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

四川大学华西医院生物医学大数据研究院

Applicant's institution:

West China Biomedical Big Data Center, West China Hospital, Sichuan University

研究负责人所在单位:

四川大学华西医院生物医学大数据研究院;四川大学华西医院麻醉科

Affiliation of the Leader:

West China Biomedical Big Data Center, West China Hospital, Sichuan University; Department of Anesthesiology, West China Hospital, Sichuan University;

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2020年审(469)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

四川大学华西医院生物医学伦理委员会

Name of the ethic committee:

Ethics Committee on Biomedical Research, West China Hospital of Sichuan University

伦理委员会批准日期:

Date of approved by ethic committee:

2020-06-10 00:00:00

伦理委员会联系人:

李娜

Contact Name of the ethic committee:

Na Li

伦理委员会联系地址:

四川省成都市武侯区国学巷37号

Contact Address of the ethic committee:

No. 37, Guoxue Lane, Wuhou District, Chengdu City, Sichuan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 85422851

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

四川大学华西医院

Primary sponsor:

West China Hospital, Sichuan University

研究实施负责(组长)单位地址:

四川省成都市武侯区国学巷37号

Primary sponsor's address:

No. 37, Guoxue Lane, Wuhou District, Chengdu City, Sichuan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川省

市(区县):

成都市

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西医院

具体地址:

四川省成都市武侯区国学巷37号

Institution
hospital:

West China Hospital, Sichuan University

Address:

No. 37, Guoxue Lane, Wuhou District, Chengdu City, Sichuan Province

经费或物资来源:

给予研究者资助的基金资助

Source(s) of funding:

Funding support for investigators

研究疾病:

围术期相关结局  

Target disease:

Perioperative outcomes

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

1.建立多个医疗中心围术期手术人群从入组至术后1年的随访队列,构建手术人群预后相关的数据库; 2.研究手术人群术前心理因素/躯体因素对术后短期并发症的影响; 3.研究手术人群术前心理因素/躯体因素/社会因素对术后长期并发症的影响; 4.研究手术人群术后认知功能障碍的发生率、相关危险因素以及对预后的影响; 5.研究手术人群术后急慢性疼痛的发生率,危险因素以及对预后的影响; 6.收集手术人群的血液和头发样本,从遗传学、免疫炎症、内分泌等角度深入探究精神障碍与术后不良结局之间的生理机制。  

Objectives of Study:

1.Establish perioperative surgical cohorts across multiple medical centers, with follow-up from enrollment to one year postoperatively, and construct a database related to surgical patient prognosis. 2.Investigate the impact of preoperative psychological and somatic factors on short-term postoperative complications in surgical patients. 3.Examine the influence of preoperative psychological, somatic, and social factors on long-term postoperative complications in surgical patients. 4.Study the incidence of postoperative cognitive dysfunction in surgical patients, identify associated risk factors, and assess its impact on prognosis. 5.Investigate the incidence of acute and chronic postoperative pain, associated risk factors, and their influence on prognosis in surgical patients. 6.Collect blood and hair samples from surgical patients to explore the physiological mechanisms linking psychiatric disorders and adverse postoperative outcomes from genetic, immunoinflammatory, and endocrine perspectives.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.小学以下文化程度; 2.不能理解访谈及量表内容; 3.患者拒绝参与研究

Exclusion criteria:

1. Education level below primary school; 2. Cannot understand the interview and scale content; 3. The patient declined to participate in the study

研究实施时间:

Study execute time:

From 2020-07-01 00:00:00 To 2027-07-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-07-15 00:00:00 To 2027-07-01 00:00:00

干预措施:

Interventions:

组别:

围术期手术人群观察组

样本量:

30000

Group:

Perioperative surgical population observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川 

市(区县):

成都市 

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西医院 

单位级别:

三甲 

Institution
hospital:

West China Hospital, Sichuan University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

四川 

市(区县):

成都市 

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西天府医院 

单位级别:

三甲 

Institution
hospital:

West China Tianfu Hospital, Sichuan University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

河北省 

市(区县):

石家庄市 

Country:

China

Province:

Hebei

City:

Shijiazhuang

单位(医院):

河北医科大学第二医院 

单位级别:

三甲 

Institution
hospital:

the Second Hospital of Hebei Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖南省 

市(区县):

长沙市 

Country:

China

Province:

Hunan

City:

Changsha

单位(医院):

中南大学湘雅医院 

单位级别:

三甲 

Institution
hospital:

Xiangya Hospital of Central South University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

四川省 

市(区县):

自贡市 

Country:

China

Province:

Sichuan

City:

Zigong

单位(医院):

自贡市第四人民医院 

单位级别:

三甲 

Institution
hospital:

Zigong Fourth People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江苏省 

市(区县):

南京市 

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

南京鼓楼医院 

单位级别:

三甲 

Institution
hospital:

Nanjing Drum Tower Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

四川省 

市(区县):

成都市 

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

成都市龙泉驿区第一人民医院 

单位级别:

三甲 

Institution
hospital:

The First People’s Hospital of Longquanyi District, Chengdu

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

四川省 

市(区县):

绵阳市 

Country:

China

Province:

Sichuan

City:

Mianyang

单位(医院):

四川绵阳四〇四医院 

单位级别:

三甲 

Institution
hospital:

Mianyang 404 Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

四川省 

市(区县):

内江市 

Country:

China

Province:

Sichuan

City:

Neijiang

单位(医院):

内江市东兴区人民医院 

单位级别:

三甲 

Institution
hospital:

People’s Hospital of Dongxing District, Neijiang

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

四川省 

市(区县):

成都市 

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川友谊医院 

单位级别:

三甲 

Institution
hospital:

Sichuan Friendship Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后并发症

指标类型:

主要指标

Outcome:

Postoperative complications

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后急慢性疼痛

指标类型:

次要指标

Outcome:

Postoperative acute/chronic pain

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后认知功能障碍

指标类型:

次要指标

Outcome:

Postoperative cognitive disorder/impairment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后康复质量

指标类型:

次要指标

Outcome:

Quality of postoperative recovery

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

其他围术期结局

指标类型:

次要指标

Outcome:

Other perioperative outcomes

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

标本中文名:

头发

组织:

Sample Name:

Hair

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture, EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-06-21 19:21:07